Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Alvotech USA Inc. et al v. Abbvie Inc et al
Case Number:
1:21-cv-05645
Court:
Nature of Suit:
Judge:
Honorable Rebecca R. Pallmeyer
Firms
Companies
Sectors & Industries:
-
March 09, 2022
Alvotech, AbbVie Deal Allows For Humira Biosimilar In 2023
Icelandic biopharmaceutical firm Alvotech has settled an intellectual property fight with AbbVie Inc. over Alvotech's proposed biosimilar version of AbbVie's blockbuster drug Humira, which is used to treat arthritis and other conditions.
-
October 22, 2021
Virginia Judge Ships Suit Over AbbVie's Humira To Illinois
A Virginia federal judge on Friday transferred a declaratory judgment suit from a potential AbbVie Inc. rival hoping to make a biosimilar of its blockbuster immunosuppressant Humira to Illinois, saying the transfer order rendered a bid by AbbVie for dismissal moot.